The effect of social deprivation on clinical outcomes and the use of treatments in the UK cystic fibrosis population: A longitudinal study

The Lancet Respiratory Medicine

Volumn 1, Issue 2, 2013, Pages 121-128

  Taylor Robinson, David C ^a   Smyth, Rosalind L ^b   Diggle, Peter J ^a   Whitehead, Margaret ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DEOXYRIBONUCLEASE;

ADULT; AGE DISTRIBUTION; ARTICLE; BACTERIAL COLONIZATION; BODY HEIGHT; BODY MASS; CAUCASIAN; COMMUNITY ASSESSMENT; CONTROLLED STUDY; CYSTIC FIBROSIS; DIET THERAPY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; GENDER; HEALTH DISPARITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL SUPPORT; POPULATION RESEARCH; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; SCORING SYSTEM; SOCIAL ISOLATION; UNITED KINGDOM;

ADULT; ANTI-BACTERIAL AGENTS; BODY MASS INDEX; CHILD; CHILD DEVELOPMENT; CYSTIC FIBROSIS; DRUG ADMINISTRATION ROUTES; FEMALE; FORCED EXPIRATORY VOLUME; GREAT BRITAIN; HUMANS; INFANT, NEWBORN; LONGITUDINAL STUDIES; MALE; ODDS RATIO; OUTCOME ASSESSMENT (HEALTH CARE); POVERTY AREAS; PSEUDOMONAS INFECTIONS; RESPIRATORY TRACT INFECTIONS; SOCIOECONOMIC FACTORS;

EID: 84880046700     PISSN: 22132600     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-2600(13)70002-X     Document Type: Article

References (34)

1. UK CF Registry annual data report 2010 Cystic Fibrosis Trust, (accessed Sept 28, 2012). http://www.cftrust.org.uk/aboutcf/publications/cfregistryreports/.
2. Schechter MS, Shelton BJ, Margolis PA, Fitzsimmons SC The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. Am J Respir Crit Care Med 2001, 163:1331-1337.
3. O'Connor GT, Quinton HB, Kneeland T, et al. Median household income and mortality rate in cystic fibrosis. Pediatrics 2003, 111:e333-e339.
4. Britton JR Effects of social class, sex, and region of residence on age at death from cystic fibrosis. BMJ 1989, 298:483-487.
5. Barr HLSA, Fogarty AW The association between socioeconomic status and gender with median age at death from cystic fibrosis in England and Wales: 1959 to 2008. BMJ 2011, 343:d4662.
6. Marmot MJ, Goldblatt P, Boyce T, McNeish D, Grady M, Geddes I Fair society, healthy lives: strategic review of health inequalities in England post-2010 2010, The Marmot Review, London.
7. Ben-Shlomo Y, Kuh D A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. Int J Epidemiol 2002, 31:285-293.
8. Stirbu I, Kunst AE, Mielck A, Mackenbach JP Inequalities in utilisation of general practitioner and specialist services in 9 European countries. BMC Health Serv Res 2011, 11:288.
9. van Doorslaer E, Masseria C, Koolman X Inequalities in access to medical care by income in developed countries. CMAJ 2006, 174:177-183.
10. Hart JT The inverse care law. Lancet 1971, 1:405-412.
11. UK CF Registry Cystic Fibrosis Trust, (accessed Jan 15, 2013). http://www.cftrust.org.uk/aboutcf/publications/cfregistryreports/.
12. Adler AI, Shine BS, Chamnan P, Haworth CS, Bilton D Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults. Diabetes Care 2008, 31:1789-1794.
13. Mehta G, Sims EJ, Culross F, McCormick JD, Mehta A Potential benefits of the UK Cystic Fibrosis Database. J R Soc Med 2004, 97:60-71.
14. Pan H, Cole T User's guide to LmsGrowth 2005, Medical Research Council, London.
15. Welcome to GeoConvert Geoconvert, (accessed Dec 22, 2012). http://geoconvert.mimas.ac.uk/.
16. Laird NM, Ware JH Random-effects models for longitudinal data. Biometrics 1982, 38:963-974.
17. Schechter MS, McColley SA, Silva S, Haselkorn T, Konstan MW, Wagener JS Association of socioeconomic status with the use of chronic therapies and healthcare utilization in children with cystic fibrosis. J Pediatr 2009, 155:634-639.
18. Schechter MS, McColley SA, Regelmann W, et al. Socioeconomic status and the likelihood of antibiotic treatment for signs and symptoms of pulmonary exacerbation in children with cystic fibrosis. J Pediatr 2011, 159:819-824.
19. Krieger N, Waterman P, Chen JT, Soobader MJ, Subramanian SV, Carson R Zip code caveat: bias due to spatiotemporal mismatches between zip codes and US census-defined geographic areas-the Public Health Disparities Geocoding Project. Am J Public Health 2002, 92:1100-1102.
20. Taylor-Robinson D, Whitehead M, Diderichsen F, et al. Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study. Thorax 2012, 67:860-866.
21. Howe LD, Tilling K, Galobardes B, Smith GD, Gunnell D, Lawlor DA Socioeconomic differences in childhood growth trajectories: at what age do height inequalities emerge?. J Epidemiol Community Health 2012, 66:143-148.
22. Howe LD, Tilling K, Galobardes B, Smith GD, Ness AR, Lawlor DA Socioeconomic disparities in trajectories of adiposity across childhood. Int J Pediatr Obes 2011, 6:e144-e153.
23. Kinra S, Baumer JH, Davey Smith G Early growth and childhood obesity: a historical cohort study. Arch Dis Child 2005, 90:1122-1127.
24. Wijlaars LP, Johnson L, van Jaarsveld CH, Wardle J Socioeconomic status and weight gain in early infancy. Int J Obes (Lond) 2011, 35:963-970.
25. Closing the gap in a generation: health equity through action on the social determinants of health. Final report of the commission on social determinants of health CSDH, (accessed Jan 15, 2013). http://whqlibdoc.who.int/publications/2008/9789241563703_eng.pdf.
26. Whitehead M, Dahlgren G Concepts and principles for tackling social inequities in health: levelling up part 1 2007, WHO, Copenhagen.
27. Southern KW, Merelle MM, Dankert-Roelse JE, Nagelkerke AD Newborn screening for cystic fibrosis. Cochrane Database Syst Rev 2009, 1. CD001402.
28. Rosenfeld M, Emerson J, McNamara S, et al. Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort. J Cyst Fibros 2012, 11:446-453.
29. Schechter MS Nongenetic influences on cystic fibrosis outcomes. Curr Opin Pulm Med 2011, 17:448-454.
30. Hanratty B, Zhang T, Whitehead M How close have universal health systems come to achieving equity in use of curative services? A systematic review. Int J Health Serv 2007, 37:89-109.
31. Groholt EK, Stigum H, Nordhagen R, Kohler L Health service utilization in the Nordic countries in 1996: influence of socio-economic factors among children with and without chronic health conditions. Eur J Public Health 2003, 13:30-37.
32. Pressler T Review of recombinant human deoxyribonuclease (rhDNase) in the management of patients with cystic fibrosis. Biologics 2008, 2:611-617.
33. Mackenbach JP What would happen to health inequalities if smoking were eliminated?. BMJ 2011, 342:d3460.
34. Taylor-Robinson D, Schechter MS Health inequalities and cystic fibrosis. BMJ 2011, 343:d4818.